CASC2a gene is down-regulated in endometrial cancer

Anticancer Research

Volumn 27, Issue 1 A, 2007, Pages 235-244

  Baldinu, Paola ^a   Cossu, Antonio ^b   Manca, Antonella ^a   Satta, Maria P ^a   Sini, Maria C ^a   Palomba, Grazia ^a   Dessole, Salvatore ^c   Cherchi, Pierluigi ^c   Mara, Laura ^d   Tanda, Francesco ^b   Palmieri, Giuseppe ^a,e  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b Servizio di Anatomia Patologica   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d Istituto Zootecnico e Caseario Per la Sardegna   (Italy)

^e Istituto Chimica Biomolecolare Consiglio Nazionale Ricerche (ICB CNR)   (Italy)

Author keywords

Anchorage independent growth; Endometrial cancer cell line; Expression analysis; Real time RT PCR; Soft agar; Tumour suppressor gene

Indexed keywords

MESSENGER RNA;

ARTICLE; CARCINOGENESIS; CASC2A GENE; CELL GROWTH; CHROMOSOME 10Q; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN GENETICS; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RNA, MESSENGER; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33847651031     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kinzler KW and Vogelstein B: Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761-763, 1997.
2. Bristow RE: Endometrial cancer. Curr Opin Oncol 11: 388-393, 1999.
3. Parkin DM, Whelan SL, Ferlay J, Teppo L and Thomas D: Cancer incidence in five continents. Lyon: IARC Press, Vol. VIII, pp. 380-381, 2003.
4. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
5. Fearon ER: Human cancer syndromes: clues to the origin and nature of cancer. Science 278: 1043-1050, 1997.
6. Honda T, Kato H, Imamura T, Gima T, Nishida JI, Sasaki M, Hoshi K, Sato A and Wake N: Involvement of p53 gene mutations in human endometrial carcinomas. Int J Cancer 53: 963-967, 1993.
7. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A: PTEN1 is frequently mutated in primary endometrial carcinomas. Nature Genet 17: 143-144, 1997.
8. Risinger JI, Hayes KA, Berchuck A and Barrett C: PTEN/ MMAC1 mutations in endometrial cancers. Cancer Res 57: 4736-4738, 1997.
9. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ and Goodfellow PJ: Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55: 1922-1926, 1995.
10. Sonoda G, du Manoir S, Godwin AK, Bell DW, Liu Z, Hogan M, Yakushiji M and Testa JR: Detection of gain and losses in primary endometrial carcinomas by comparative genomic hybridization. Genes Chrom Cancer 18: 115-125, 1997.
11. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV: Identification of a candidate tumour suppressor gene MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
12. Nagase S, Yamakawa H, Sato S, Yajima A and Horii A: Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer. Cancer Res 57: 1630-1633, 1997.
13. Peiffer-Schneider S, Noonan FC, Mutch DG, Simpkins SB, Herzog T, Rader J, Elbendary A, Gersell DJ, Call K and Goodfellow PJ: Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus interval. Genomics 52: 9-16, 1998.
14. Yamakawa H, Nagase S, Yuki M, Shiwaku HO, Furukawa T, Yoshinaga K, Soeda E, Hoshi M, Hayashi Y, Sato S, Yajima A and Horii A: Identification of a 100-kb region of common allelic loss on chromosome bands 10q25-q26 in human endometrial cancer. Genes Chromosomes Cancer 23: 74-77, 1998.
15. Palmieri G, Manca A, Cossu A, Ruiu G, Pisano M, Cherchi P, Dessole S, Pintus A, Massarelli G, Tanda F and Pirastu M: Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma: identification of specification patterns of genetic alteration. Cancer 89: 1773-1782, 2000.
16. Baldinu P, Cossu A, Manca A, Satta MP, Sini MC, Rozzo C, Dessole S, Cherchi P, Gianfrancesco F, Pintus A, Carboni A, Deiana A, Tanda F and Palmieri G: Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. Hum Mutat 23: 318-326, 2004.
17. Palmieri G, Ascierto PA, Cossu A, Mozzillo N, Motti ML, Satriano SM, Botti G, Caraco C, Celentano E, Satriano RA, Lissia A, Tanda F, Pirastu M and Castello G: Detection of occult melanoma cells in paraffin-embedded histologically-negative sentinel lymph nodes using a reverse transcriptase-polymerase chain reaction assay. J Clin Oncol 19: 1437-1443, 2001.
18. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis. Nature 363: 558-561, 1993.
19. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, David L, Holm R, Ryberg D and Haugen A: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53: 5853-5955, 1993.
20. Baldinu P, Cossu A, Manca A, Satta MP, Pisano M, Casula M, Dessole S, Pintus A, Tanda F and Palmieri G: Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma. Cancer 94: 3157-3168, 2002.
21. Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R and Advani H: The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. Cancer 68: 2293-2302, 1991.
22. Saegusa M and Okayasu I: Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. Pathol 194: 59-67, 2001.
23. Murray SK, Young RH and Scully RE: Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Int J Gynecol Pathol 22: 324-333, 2003.
24. Jones PA and Laird PW: Cancer epigenetics comes of age. Nat Genet 21: 163-167, 1999.
25. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686, 1999.
26. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumours and mismatch repair-defective human tumour cell lines. Cancer Res 57: 808-811, 1997.
27. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870-6875, 1998.
28. Strazzullo M, Cossu A, Baldinu P, Colombino M, Satta MP, Tanda F, De Bonis ML, Cerase A, D'Urso M, D'Esposito M and Palmieri G: High-resolution methylation analysis of hMLH1 promoter in sporadic endometrial and colorectal carcinomas. Cancer 98: 1540-1546, 2003.